HomeCompareIPGGF vs MRK

IPGGF vs MRK: Dividend Comparison 2026

IPGGF yields 1654.26% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IPGGF wins by $1717759004.81M in total portfolio value
10 years
IPGGF
IPGGF
● Live price
1654.26%
Share price
$0.12
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1717759004.87M
Annual income
$1,535,201,583,860,889.20
Full IPGGF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — IPGGF vs MRK

📍 IPGGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIPGGFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IPGGF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IPGGF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IPGGF
Annual income on $10K today (after 15% tax)
$140,612.08/yr
After 10yr DRIP, annual income (after tax)
$1,304,921,346,281,755.80/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, IPGGF beats the other by $1,304,921,346,273,159.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IPGGF + MRK for your $10,000?

IPGGF: 50%MRK: 50%
100% MRK50/50100% IPGGF
Portfolio after 10yr
$858879502.46M
Annual income
$767,600,791,935,501.50/yr
Blended yield
89.37%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

IPGGF
No analyst data
Altman Z
-1.4
Piotroski
4/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IPGGF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIPGGFMRK
Forward yield1654.26%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$1717759004.87M$57.7K
Annual income after 10y$1,535,201,583,860,889.20$10,113.78
Total dividends collected$1704592643.43M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: IPGGF vs MRK ($10,000, DRIP)

YearIPGGF PortfolioIPGGF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$176,126$165,425.97$11,213$373.04+$164.9KIPGGF
2$2,911,428$2,722,972.90$12,667$512.06+$2.90MIPGGF
3$45,182,286$42,067,058.76$14,439$708.14+$45.17MIPGGF
4$658,472,498$610,127,451.75$16,640$988.16+$658.46MIPGGF
5$9,014,665,096$8,310,099,522.47$19,432$1,394.07+$9014.65MIPGGF
6$115,970,449,730$106,324,758,077.57$23,057$1,992.90+$115970.43MIPGGF
7$1,402,434,243,410$1,278,345,862,199.39$27,889$2,894.79+$1402434.22MIPGGF
8$15,948,339,348,371$14,447,734,707,921.60$34,518$4,286.29+$15948339.31MIPGGF
9$170,614,412,158,911$153,549,689,056,154.40$43,912$6,494.35+$170614412.11MIPGGF
10$1,717,759,004,870,924$1,535,201,583,860,889.20$57,714$10,113.78+$1717759004.81MIPGGF

IPGGF vs MRK: Complete Analysis 2026

IPGGFStock

Imperium Technology Group Limited, an investment holding company, manufactures and sells household furnishing products and accessories. The company operates through six segments: Game Publishing, Cloud Computing and Data Storage, Esports, Household Products, Property Investment, and Money Lending. It produces stainless steel home furnishing products for kitchens and bathrooms; and offers diversified financial products, including personal loans, home mortgages, equity financing and mortgage, and corporate finance. The company is also involved in cryptocurrency mining and rental of machines to customers to engage in cryptocurrency mining; and participating in esports competitions, streaming and marketing events, and merchandise sales. In addition, it invests in properties; and designs and develops mobile and computer games in Hong Kong, the People's Republic of China, East and South Asia, and internationally. The company was formerly known as Imperium Group Global Holdings Limited and changed its name to Imperium Technology Group Limited in July 2021. Imperium Technology Group Limited was founded in 1999 and is based in Kwun Tong, Hong Kong. Imperium Technology Group Limited is a subsidiary of Diamond State Holdings Limited.

Full IPGGF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this IPGGF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IPGGF vs SCHDIPGGF vs JEPIIPGGF vs OIPGGF vs KOIPGGF vs MAINIPGGF vs JNJIPGGF vs ABBVIPGGF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.